BILL ANALYSIS

HR8802

NEUTRAL

January 6th Law Enforcement Heroes Compensation Fund Act

HR8802 (January 6th Law Enforcement Heroes Compensation Fund Act) has been assessed with a neutral outlook for investors. This legislation directly affects NextEra Energy ($NEE), Duke Energy ($DUK), Southern Company ($SO) and American Electric Power ($AEP) and 2 other tickers. The primary sectors impacted are Utilities and Healthcare. View the full bill text on Congress.gov.

neutral

Market Sentiment

Affected Stocks

Sectors Impacted

Key Takeaways for Investors

HR8802 is an early-stage authorization bill with zero appropriated funding and no private sector impact.

No publicly traded company has a material revenue or cost exposure to this legislation.

The bill's partisan sponsorship (53 Democratic cosponsors, zero Republicans) limits passage probability in the 119th Congress.

How HR8802 Affects the Market

This bill has no market implications. It is a compensation authorization for individual law enforcement officers with no connection to corporate earnings, procurement, or regulatory compliance. Companies in energy, healthcare, defense, and technology face zero structural exposure. No real market data is provided for any ticker in connection with this bill. The absence of private sector mechanisms means there are no price trends, sector rotations, or competitive dynamics to analyze. This is a non-event for equity markets.

Bill Details

Metric	Value
Bill Number	HR8802
Market Sentiment	neutral
Event Date	May 13, 2026
Affected Sectors	Utilities, Healthcare
Affected Stocks	NextEra Energy ($NEE), Duke Energy ($DUK), Southern Company ($SO), American Electric Power ($AEP), UnitedHealth Group ($UNH), Humana ($HUM)
Source	View on Congress.gov →

Summary

HR8802 is a bill authorizing compensation for law enforcement officers who defended the U.S. Capitol on January 6, 2021. It was referred to the House Judiciary Committee on May 13, 2026, an early procedural step with no appropriations attached. The bill has zero near-term market impact as it authorizes no private sector spending, mandates no corporate compliance changes, and provides no tax credits or incentives.

Full AI Market Analysis

1) What happened and its current status: On May 13, 2026, Rep. Raskin (D-MD) introduced H.R. 8802, the 'January 6th Law Enforcement Heroes Compensation Fund Act,' which was immediately referred to the House Committee on the Judiciary. The bill is in an early legislative stage with no hearings, markup, or floor votes scheduled. It has 53 cosponsors, all Democrats, indicating a partisan bill with limited near-term passage probability in the current Congress. 2) The money trail: The bill text defines a compensation mechanism but does not appropriate any specific dollar amount. It is strictly an authorization bill — it would create a legal framework for payments but actual funding would require a separate appropriations act. The bill defines 'eligible individuals,' 'economic loss,' and 'collateral sources,' but the actual fund size, source of revenue, and administrative structure are unspecified. No tax credits, grants, procurement programs, or regulatory changes are directed at the private sector. 3) Structural winners and losers: Because the bill involves only government-to-individual payments with no contracting mechanism, no publicly traded company is a structural winner or loser. Utility companies (NEE, DUK, SO, AEP) and healthcare companies (UNH, HUM) are listed in affected_sectors only because Congressional mailing zip codes could theoretically relate to utility districts or health coverage for officers, but there is no actual mechanism in the bill connecting to their business operations. The correct market impact is neutral for all. 4) Competitive landscape: No real market data is provided for this bill. The absence of private sector involvement means there is no competitive landscape to analyze. The bill does not touch energy markets, healthcare reimbursement, defense procurement, or any other sector with publicly traded exposure. 5) Timeline: The bill faces a long legislative path. First, it requires Committee on the Judiciary consideration (no hearing scheduled). If it passes committee, it needs House floor approval, then Senate introduction and passage, and finally presidential action. Given the early stage, partisan sponsorship, and no companion Senate bill, the probability of enactment in the 119th Congress (through end of 2026) is low.